Second, QB1561 at low concentrations, could partially reverse resistance of mitoxantrone or topotecan mediated in ABCG2-overexpressing NCI-H460/MX20 lung cancer cells, suggesting it can serve as a new ABCG2 regulator. Here, ABCG2 is linked to lung cancer.